<DOC>
	<DOCNO>NCT01448382</DOCNO>
	<brief_summary>1 . Primary Scientific Objective - Collect human clinical data sustain development blood detection sensor optimize algorithm parameter - Preliminary evaluation blood detection performance human . 2 . Secondary Scientific Objective - Assessment blood detection sensor ability identify anatomical location ( i.e . Stomach , SB Colon ) - Evaluation capsule transit characteristic GI tract - Evaluation BBC capsule safety Study Hypothesis : It estimate implement spectrophotometer technology capsule utilize unique characteristic light absorption blood specific spectrum , capsule able automatically detect blood GI tract high accuracy . As , system may add-on video capsule provide efficient quick detection blood presence ( example OGBI patient ) stand alone low cost capsule ( without video ) could serve tool similar standard FOBT .</brief_summary>
	<brief_title>Evaluation PillCam With Blood-Sensing Feature : A Feasibility Study</brief_title>
	<detailed_description>This study design support development novel blood sense detector embed PillCam® capsule provide initial evaluation performance human . The device name Blood Sensing Capsule ( BSC ) , base Given PillCam® Platform modify capsule .</detailed_description>
	<criteria>Group A ( Healthy subject ) Subject 's age 18 45 year old Subject healthy volunteer Subject agree sign Informed Consent Form Group B ( Symptomatic Patients ) Age ≥ 18 year The subject refer Gastroscopy least one follow reason : 1 . History acute , overt UGI hemorrhage , define hematemesis ( fresh blood coffee ground ) and/or melena within 48 hour prior patient presentation 2 . Subject ongoing overt gastrointestinal bleeding hematochezia melena 3 . Subject Iron Deficiency Anemia , FOBT ( + ) negative colonoscopy examination 4 . Other know suspect cause acute upper GI bleeding Subject agree sign Informed Consent Form 1 . Subject Dysphagia , odynophagia , know swallow disorder history Zencker 's diverticulum 2 . Subject know suspected suffer bowel obstruction bowel perforation time presentation 3 . Subject history prior bowel obstruction 4 . Subject suffers UGI hemorrhage hemodynamic shock require urgent endoscopy 5 . Subject condition believe increase risk capsule retention Crohn 's disease , intestinal tumor , radiation enteritis , incomplete colonoscopy due obstruction NSAID enteropathy 6 . Subject history UGI tract surgery ( e.g. , Billroth I , Billroth II , esophagectomy , gastrectomy , bariatric procedure ) 7 . Pregnancy nurse mother 8 . Subject know allergy conscious sedation medication 9 . Presence electromedical device ( pacemaker internal cardiac defibrillator ) 10 . Subject alter mental status ( e.g. , hepatic encephalopathy ) would limit patient ability swallow capsule 11 . Known allergy erythromycin 12 . Subject currently within previous 30 day participate another clinical study may directly indirectly affect result study 13 . Subject able provide write informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>